The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial

NCT02401828 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Dolutegravir

Sponsor

Erasmus Medical Center